These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 22435948
1. Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial. Araki S, Nishio Y, Araki A, Umegaki H, Sakurai T, Iimuro S, Ohashi Y, Uzu T, Maegawa H, Kashiwagi A, Ito H, Japanese Elderly Intervention Trial Research Group. Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():127-33. PubMed ID: 22435948 [Abstract] [Full Text] [Related]
3. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes. Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y. Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763 [Abstract] [Full Text] [Related]
5. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Hanai K, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Bouchi R, Tanaka N, Ishii A, Iwamoto Y. Nephrol Dial Transplant; 2012 Mar; 27(3):1070-5. PubMed ID: 21785041 [Abstract] [Full Text] [Related]
10. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H. J Diabetes Complications; 2008 Mar; 22(6):384-8. PubMed ID: 18413152 [Abstract] [Full Text] [Related]
15. Concomitant macro and microvascular complications in diabetic nephropathy. Alwakeel JS, Al-Suwaida A, Isnani AC, Al-Harbi A, Alam A. Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942 [Abstract] [Full Text] [Related]
16. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A. Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814 [Abstract] [Full Text] [Related]
17. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187 [Abstract] [Full Text] [Related]
18. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H, Japanese Elderly Diabetes Intervention Trial Research Group. Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944 [Abstract] [Full Text] [Related]
19. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy]. Martínez-Castelao A, Ramos R, González MT, Castiñeiras MJ. Nefrologia; 2002 Apr; 22 Suppl 1():51-8. PubMed ID: 11987671 [Abstract] [Full Text] [Related]
20. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes]. Bulum T, Duvnjak L, Prkacin I. Acta Med Croatica; 2011 Apr; 65(3):243-50. PubMed ID: 22359892 [Abstract] [Full Text] [Related] Page: [Next] [New Search]